143 related articles for article (PubMed ID: 25789346)
1. Painless penile papule.
Marszalek RM; Bae-Harboe YS; Mahalingam M; Masterpol K
J Fam Pract; 2015 Mar; 64(3):185-8. PubMed ID: 25789346
[No Abstract] [Full Text] [Related]
2. Malignant syphilis in a HIV infected patient.
Jalili A; Mosleh M; Grabmeier-Pfistershammer K; Loewe R; Stingl G; Rieger A
Sex Transm Dis; 2015 Apr; 42(4):223-5. PubMed ID: 25763666
[TBL] [Abstract][Full Text] [Related]
3. [Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV].
Bayonne Kombo ES; Gathse A
Med Mal Infect; 2013 Mar; 43(3):134-5. PubMed ID: 23434355
[No Abstract] [Full Text] [Related]
4. Number of daily pills, dosing schedule, self-reported adherence and health status in 2010: a large cross-sectional study of HIV-infected patients on antiretroviral therapy.
Gianotti N; Galli L; Bocchiola B; Cahua T; Panzini P; Zandonà D; Salpietro S; Maillard M; Danise A; Pazzi A; Lazzarin A; Castagna A
HIV Med; 2013 Mar; 14(3):153-60. PubMed ID: 22994659
[TBL] [Abstract][Full Text] [Related]
5. Combination antiretroviral therapy with tenofovir, emtricitabine or lamivudine, and nevirapine.
Redfield RR; Morrow JS
Clin Infect Dis; 2008 Oct; 47(7):984-5. PubMed ID: 18778234
[No Abstract] [Full Text] [Related]
6. Risk of early virological failure of once-daily tenofovir-emtricitabine plus twice-daily nevirapine in antiretroviral therapy-naive HIV-infected patients.
Lapadula G; Costarelli S; Quiros-Roldan E; Calabresi A; Izzo I; Carosi G; Torti C
Clin Infect Dis; 2008 Apr; 46(7):1127-9. PubMed ID: 18444839
[No Abstract] [Full Text] [Related]
7. The continuing evolution of HIV therapy.
Boyle BA
AIDS Read; 2003 Dec; 13(12):576-8, 582. PubMed ID: 14959692
[No Abstract] [Full Text] [Related]
8. Safety and efficacy of tenofovir/emtricitabine plus nevirapine in HIV-infected patients.
Labarga P; Medrano J; Seclen E; Poveda E; Rodriguez-Novoa S; Morello J; de Mendoza C; Vispo E; Soriano V
AIDS; 2010 Mar; 24(5):777-9. PubMed ID: 20168201
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of tenofovir/emtricitabine or abacavir/lamivudine in combination with efavirenz in treatment naïve HIV patients: a 5 year retrospective observational cohort study. (the TOKEN Study).
Pammi M; Arumainayagam J; Kumari B; Ahmed-Jushuf I; Carlin EM; Chandramani S; Riddell L; Ghanem M; Das S
Int J Clin Pract; 2013 Sep; 67(9):922-3. PubMed ID: 23952469
[No Abstract] [Full Text] [Related]
10. [Efavirenz in fixed combination with tenofovir and emtricitabine. Long-term effectiveness verified in new studies].
Wepner U
MMW Fortschr Med; 2011 May; 153(18):20-1. PubMed ID: 21604586
[No Abstract] [Full Text] [Related]
11. Pathologically confirmed malignant syphilis using immunohistochemical staining: report of 3 cases and review of the literature.
Cid PM; Cudós ES; Zamora Vargas FX; Merino MJ; Pinto PH
Sex Transm Dis; 2014 Feb; 41(2):94-7. PubMed ID: 24413487
[TBL] [Abstract][Full Text] [Related]
12. Antiretroviral chemoprophylaxis: new successes and questions.
Mayer KH
Lancet; 2015 Jun; 385(9984):2236-7. PubMed ID: 25769358
[No Abstract] [Full Text] [Related]
13. Warning on two specific 3-drug regimens: Viread + Didanosine + either Sustiva or Viramune.
AIDS Treat News; 2004 Oct; (406):5. PubMed ID: 15614963
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of adherence and efficiency when replacing an antiretroviral therapy with efavirenz-emtricitabine-tenofovir in a single daily dose].
García-Ramos SE; Santolaya Perrín MR; Fernández-Pacheco García-Valdecasas M
Farm Hosp; 2012; 36(5):315-20. PubMed ID: 22858089
[TBL] [Abstract][Full Text] [Related]
15. Antiretrovirals for HIV prevention: translating promise into praxis.
Mayer KH
Lancet; 2011 Jul; 378(9787):206-8. PubMed ID: 21763922
[No Abstract] [Full Text] [Related]
16. Pustulocrustaceous secondary syphilis.
Aggarwal K; Gupta S; Jain VK
Acta Derm Venereol; 2005; 85(4):378-9. PubMed ID: 16191874
[No Abstract] [Full Text] [Related]
17. Regression of HIV-related diffuse large B-cell lymphoma in response to antiviral therapy alone.
Amengual JE; Zhang X; Ibrahim S; Gardner LB
Blood; 2008 Nov; 112(10):4359-60. PubMed ID: 18988884
[No Abstract] [Full Text] [Related]
18. New once-daily HIV combination better tolerated.
Expert Rev Anti Infect Ther; 2004 Dec; 2(6):826. PubMed ID: 15566325
[No Abstract] [Full Text] [Related]
19. Once-daily dosing and the treatment of HIV disease.
Laurence J
AIDS Read; 2006 Sep; 16(9):444-5. PubMed ID: 17024761
[No Abstract] [Full Text] [Related]
20. Pre-exposure prophylaxis works--it's time to deliver.
Beyrer C; Bekker LG; Pozniak A; Barré-Sinoussi F
Lancet; 2015 Apr; 385(9977):1482-4. PubMed ID: 25933264
[No Abstract] [Full Text] [Related]
[Next] [New Search]
